Medical Care Technologies Develops Melanoma Scan

Medical Care Technologies Inc. is actively developing and testing its MDCE Melanoma Scan Beta platform, an AI-assisted imaging application designed for long-term visual tracking and organization of skin images to support preventative health awareness. The company has initiated internal beta testing to focus on platform stability, workflow optimization, and image consistency. Medical Care Technologies Inc. has also provided insights into its long-term strategic vision, which extends beyond this single application to explore broader AI-assisted imaging technologies and scalable image analysis infrastructure across consumer, wellness, enterprise, and medical technology sectors. Marshall Perkins, CEO of Medical Care Technologies Inc., emphasized the objective to build a technology foundation for future innovation. The platform's user experience is being refined to include streamlined body-map tracking and image management features, aiming for intuitive image organization and accessibility. The MDCE Melanoma Scan Beta platform is currently in beta-stage development and has not yet received regulatory clearance from the United States — Food and Drug Administration, meaning it is not intended to diagnose, treat, cure, or prevent any disease or medical condition.